Clinical Trial: Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Benign Breast Neoplasm
Study Type: INTERVENTIONAL
Official Title: Targeted Prevention of Postpartum-Related Breast Cancer
Brief Summary:
This phase II trial tests whether low-dose aspirin can affect markers of inflammation in postpartum (after childbirth) patients with benign breast disease planning to have a breast biopsy.Chronic inflammation may increase the risk of postpartum related breast cancer.Low-dose aspirin is a non-steroidal anti-inflammatory drug.Giving low-dose aspirin may affect markers of inflammation in blood and tissue and may prevent postpartum related breast cancer.
Read more